Chen Yan - Net Worth and Insider Trading
Chen Yan Net Worth
The estimated net worth of Chen Yan is at least $23 Million dollars as of 2025-07-23. Chen Yan is the Director of Henan Lingrui Pharmaceutical Co Ltd and owns about 965,000 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) stock worth over $23 Million. Details can be seen in Chen Yan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chen Yan has not made any transactions after 2025-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Chen Yan
Chen Yan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chen Yan owns 1 companies in total, including Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) .
Click here to see the complete history of Chen Yan’s form 4 insider trades.
Insider Ownership Summary of Chen Yan
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2025-01-09 | Directors & senior managers |
Chen Yan Latest Holdings Summary
Chen Yan currently owns a total of 1 stock. Chen Yan owns 965,000 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) as of January 9, 2025, with a value of $23 Million.
Latest Holdings of Chen Yan
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2025-01-09 | 965,000 | 23.38 | 22,561,700 |
Holding Weightings of Chen Yan
Chen Yan Form 4 Trading Tracker
According to the SEC Form 4 filings, Chen Yan has made a total of 2 transactions in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Henan Lingrui Pharmaceutical Co Ltd is the sale of 150,000 shares on January 9, 2025, which brought Chen Yan around $2 Million.
Insider Trading History of Chen Yan
- 1
Chen Yan Trading Performance
GuruFocus tracks the stock performance after each of Chen Yan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chen Yan is -15.18%. GuruFocus also compares Chen Yan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chen Yan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chen Yan's insider trading performs compared to the benchmark.
Chen Yan Ownership Network
Ownership Network List of Chen Yan
Ownership Network Relation of Chen Yan

Chen Yan Owned Company Details
What does Henan Lingrui Pharmaceutical Co Ltd do?
Who are the key executives at Henan Lingrui Pharmaceutical Co Ltd?
Chen Yan is the Directors & senior managers of Henan Lingrui Pharmaceutical Co Ltd. Other key executives at Henan Lingrui Pharmaceutical Co Ltd include senior management Ye Qiang , senior management Wu Hui Bin , and senior management Li Lei .
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) Insider Trades Summary
Over the past 18 months, Chen Yan made 1 insider transaction in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) with a net sale of 0. Other recent insider transactions involving Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) include a net sale of 138,500 shares made by Wu Xi Zhen , a net sale of 47,600 shares made by Li Jin , and a net sale of 0 shares made by Pan Zi Run .
In summary, during the past 3 months, insiders sold 0 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 186,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) were sold and 0 shares were bought by its insiders, resulting in a net sale of 186,100 shares.
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285)'s detailed insider trading history can be found in Insider Trading Tracker table.
Henan Lingrui Pharmaceutical Co Ltd Insider Transactions
Chen Yan Mailing Address
Above is the net worth, insider trading, and ownership report for Chen Yan. Currently GuruFocus does not have mailing address information for Chen Yan.